Of note, we found that APOBEC3A expression was also increased in patients with non-alcoholic steatohepatitis (NASH), especially in NASH in combination with fibrosis (unpublished data), suggesting that APOBEC3A may play a role in other metabolic diseases as well. This evidence concerns the gene APOBEC3A and metabolic dysfunction-associated steatohepatitis.